Cargando…

Cell-Based Therapies for Tissue Fibrosis

The development of tissue fibrosis in the context of a wound-healing response to injury is common to many chronic diseases. Unregulated or persistent fibrogenesis may lead to structural and functional changes in organs that increase the risk of significant morbidity and mortality. We will explore th...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lim, Rebecca, Ricardo, Sharon D., Sievert, William
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2017
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5626978/ https://www.ncbi.nlm.nih.gov/pubmed/29033833 http://dx.doi.org/10.3389/fphar.2017.00633

Ejemplares similares

A Pilot Study Evaluating the Safety of Intravenously Administered Human Amnion Epithelial Cells for the Treatment of Hepatic Fibrosis
por: Lim, Rebecca, et al.
Publicado: (2017)

The Human Amnion Epithelial Cell Secretome Decreases Hepatic Fibrosis in Mice with Chronic Liver Fibrosis
por: Alhomrani, Majid, et al.
Publicado: (2017)

Mesothelial cells in tissue repair and fibrosis
por: Mutsaers, Steven E., et al.
Publicado: (2015)

Treatment of Cystic Fibrosis: From Gene- to Cell-Based Therapies
por: Allan, Katelin M., et al.
Publicado: (2021)

Challenges Facing Airway Epithelial Cell-Based Therapy for Cystic Fibrosis
por: Berical, Andrew, et al.
Publicado: (2019)

P311, Friend, or Foe of Tissue Fibrosis?
por: Stradiot, Leslie, et al.
Publicado: (2018)

Targeting Certain Interleukins as Novel Treatment Options for Liver Fibrosis
por: An, Su Yeon, et al.
Publicado: (2021)

Gene therapy for cystic fibrosis: Challenges and prospects
por: Sui, Hongshu, et al.
Publicado: (2022)

Editorial: Fibrosis: etiology, pathophysiology, measurements, and therapy
por: Liu, Yanping, et al.
Publicado: (2023)

The Role of S1P and the Related Signaling Pathway in the Development of Tissue Fibrosis
por: Wang, Erjin, et al.
Publicado: (2019)

Control of Tissue Fibrosis by 5-Methoxytryptophan, an Innate Anti-Inflammatory Metabolite
por: Wu, Kenneth K
Publicado: (2021)

Metformin Mitigates Fibrosis and Glucose Intolerance Induced by Doxorubicin in Subcutaneous Adipose Tissue
por: Biondo, Luana A., et al.
Publicado: (2018)

Corrigendum: The Role of S1P and the Related Signaling Pathway in the Development of Tissue Fibrosis
por: Wang, Erjin, et al.
Publicado: (2020)

Galangin Attenuates Isoproterenol-Induced Inflammation and Fibrosis in the Cardiac Tissue of Albino Wistar Rats
por: Thangaiyan, Radhiga, et al.
Publicado: (2020)

Pharmacokinetics and tissue distribution of bleomycin-induced idiopathic pulmonary fibrosis rats treated with cryptotanshinone
por: He, Xiangjun, et al.
Publicado: (2023)

Use of a Primary Epithelial Cell Screening Tool to Investigate Phage Therapy in Cystic Fibrosis
por: Trend, Stephanie, et al.
Publicado: (2018)

Designing Clinical Trials for Anti-Inflammatory Therapies in Cystic Fibrosis
por: Perrem, Lucy, et al.
Publicado: (2020)

Editorial: The Cell Types of Fibrosis
por: Murray, Lynne A.
Publicado: (2016)

Human Primary Epithelial Cell Models: Promising Tools in the Era of Cystic Fibrosis Personalized Medicine
por: Awatade, Nikhil T., et al.
Publicado: (2018)

The epithelium in idiopathic pulmonary fibrosis: breaking the barrier
por: Camelo, Ana, et al.
Publicado: (2014)

Sphingosine 1-Phosphate Signaling as a Target in Hepatic Fibrosis Therapy
por: González-Fernández, Bárbara, et al.
Publicado: (2017)

Insights Into Patient Variability During Ivacaftor-Lumacaftor Therapy in Cystic Fibrosis
por: Hanafin, Patrick O., et al.
Publicado: (2021)

Changes in cystic fibrosis transmembrane conductance regulator protein expression prior to and during elexacaftor-tezacaftor-ivacaftor therapy
por: Stanke, Frauke, et al.
Publicado: (2023)

Cytoplasmic domain of tissue factor promotes liver fibrosis in mice
por: Knight, Virginia, et al.
Publicado: (2017)

Molecular Chaperones as Targets to Circumvent the CFTR Defect in Cystic Fibrosis
por: Chanoux, Rebecca A., et al.
Publicado: (2012)

Exploring the Mechanism Whereby Sinensetin Delays the Progression of Pulmonary Fibrosis Based on Network Pharmacology and Pulmonary Fibrosis Models
por: Xu, Yong, et al.
Publicado: (2021)

Targeting Hypoxia Inducible Factors-1α As a Novel Therapy in Fibrosis
por: Xiong, Anji, et al.
Publicado: (2017)

Gene Therapy for Cystic Fibrosis Lung Disease: Overcoming the Barriers to Translation to the Clinic
por: Donnelley, Martin, et al.
Publicado: (2018)

Progress in understanding and treating idiopathic pulmonary fibrosis: recent insights and emerging therapies
por: Guo, Hehua, et al.
Publicado: (2023)

Effects of elexacaftor/tezacaftor/ivacaftor therapy on mental health of patients with cystic fibrosis
por: Piehler, Linus, et al.
Publicado: (2023)

Comparison on different traditional Chinese medicine therapies for chronic hepatitis B liver fibrosis
por: Dai, Yun-kai, et al.
Publicado: (2022)

Real-life impact of highly effective CFTR modulator therapy in children with cystic fibrosis
por: Olivier, Margarete, et al.
Publicado: (2023)

Recent Progress in CFTR Interactome Mapping and Its Importance for Cystic Fibrosis
por: Lim, Sang Hyun, et al.
Publicado: (2018)

Effects of lumacaftor—ivacaftor therapy on cystic fibrosis transmembrane conductance regulator function in F508del homozygous patients with cystic fibrosis aged 2–11 years
por: Berges, Julian, et al.
Publicado: (2023)

Functional Gene Module–Based Identification of Phillyrin as an Anticardiac Fibrosis Agent
por: Wang, Lei, et al.
Publicado: (2020)

Indole-Based Small Molecules as Potential Therapeutic Agents for the Treatment of Fibrosis
por: Qin, Rui, et al.
Publicado: (2022)

Caveolin-1 regulates chemokine receptor 5-mediated contribution of bone marrow-derived cells to dermal fibrosis
por: Lee, Rebecca, et al.
Publicado: (2014)

Drugs and Targets in Fibrosis
por: Li, Xiaoyi, et al.
Publicado: (2017)

Pharmacological Intervention in Hepatic Stellate Cell Activation and Hepatic Fibrosis
por: Schon, Hans-Theo, et al.
Publicado: (2016)

Cell-Based Therapies for Heart Failure
por: Campos de Carvalho, Antonio Carlos, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_e2eesl0fagd40n9d5pomai21lg